It is possible that the changes in transcription during ATRA treatment are accompanied by a loss of CRC-mediated protection from ubiquitination such that these transcription factor proteins have reduced stability unless they are incorporated into a new CRC, as we observed for HAND2 and TBX2, which are retained in the retino-sympathetic CRC. Here, HAND2 is linked to colorectal carcinoma.